{"id":"https://openalex.org/W4324136994","doi":"https://doi.org/10.1200/jco.2023.41.6_suppl.tps293","title":"A phase Ib/II study (IMMCO-1) of atezolizumab plus tivozanib in castrate-resistant prostate cancer and certain other immunologically cold tumors.","display_name":"A phase Ib/II study (IMMCO-1) of atezolizumab plus tivozanib in castrate-resistant prostate cancer and certain other immunologically cold tumors.","publication_year":2023,"publication_date":"2023-02-20","ids":{"openalex":"https://openalex.org/W4324136994","doi":"https://doi.org/10.1200/jco.2023.41.6_suppl.tps293"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.6_suppl.tps293","doi":"https://doi.org/10.1200/jco.2023.41.6_suppl.tps293","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.6_suppl.tps293","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082009048","display_name":"Jonathan Alexander Chatzkel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4390039331","display_name":"UF Health Cancer Center","ror":"https://ror.org/044vhe029","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144","https://openalex.org/I4390039331"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Alexander Chatzkel","raw_affiliation_strings":["University of Florida/UF Health Cancer Center, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida/UF Health Cancer Center, Gainesville, FL","institution_ids":["https://openalex.org/I33213144","https://openalex.org/I4390039331"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100413485","display_name":"Ji\u2010Hyun Lee","orcid":"https://orcid.org/0000-0001-6420-5150","observed_orcids":["https://orcid.org/0000-0001-6420-5150","https://orcid.org/0000-0003-0450-2879"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4390039331","display_name":"UF Health Cancer Center","ror":"https://ror.org/044vhe029","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144","https://openalex.org/I4390039331"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ji-Hyun Lee","raw_affiliation_strings":["University of Florida/UF Health Cancer Center, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida/UF Health Cancer Center, Gainesville, FL","institution_ids":["https://openalex.org/I33213144","https://openalex.org/I4390039331"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000796303","display_name":"Azka Ali","orcid":"https://orcid.org/0000-0001-7476-6664","observed_orcids":["https://orcid.org/0000-0001-7476-6664"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Azka Ali","raw_affiliation_strings":["Taussig Cancer Center, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Center, Cleveland, OH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069843364","display_name":"Carmen Joseph Allegra","orcid":"https://orcid.org/0000-0001-6402-2709","observed_orcids":["https://orcid.org/0000-0001-6402-2709"]},"institutions":[{"id":"https://openalex.org/I4390039331","display_name":"UF Health Cancer Center","ror":"https://ror.org/044vhe029","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144","https://openalex.org/I4390039331"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carmen Joseph Allegra","raw_affiliation_strings":["The University of Florida Health Cancer Center - Gainsville, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Florida Health Cancer Center - Gainsville, Gainesville, FL","institution_ids":["https://openalex.org/I4390039331"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069573678","display_name":"Wayne  G. Brisbane","orcid":"https://orcid.org/0000-0003-0470-5262","observed_orcids":["https://orcid.org/0000-0003-0470-5262"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wayne Brisbane","raw_affiliation_strings":["University of Florida, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007324648","display_name":"Paul L. Crispen","orcid":"https://orcid.org/0000-0002-3699-6183","observed_orcids":["https://orcid.org/0000-0002-3699-6183"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Crispen","raw_affiliation_strings":["University of Florida, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008488764","display_name":"Padraic O\u2019Malley","orcid":"https://orcid.org/0000-0002-6273-3512","observed_orcids":["https://orcid.org/0000-0002-6273-3512","https://orcid.org/0000-0002-0837-8310"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Padraic O'Malley","raw_affiliation_strings":["University of Florida, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020154592","display_name":"Thomas J. George","orcid":"https://orcid.org/0000-0002-6249-9180","observed_orcids":["https://orcid.org/0000-0002-6249-9180"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4390039331","display_name":"UF Health Cancer Center","ror":"https://ror.org/044vhe029","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144","https://openalex.org/I4390039331"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. George","raw_affiliation_strings":["University of Florida/UF Health Cancer Center, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida/UF Health Cancer Center, Gainesville, FL","institution_ids":["https://openalex.org/I33213144","https://openalex.org/I4390039331"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063221042","display_name":"Brian Hemendra Ramnaraign","orcid":"https://orcid.org/0000-0003-4051-4551","observed_orcids":["https://orcid.org/0000-0003-4051-4551"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4390039331","display_name":"UF Health Cancer Center","ror":"https://ror.org/044vhe029","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144","https://openalex.org/I4390039331"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Hemendra Ramnaraign","raw_affiliation_strings":["University of Florida/UF Health Cancer Center, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida/UF Health Cancer Center, Gainesville, FL","institution_ids":["https://openalex.org/I33213144","https://openalex.org/I4390039331"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"6_suppl","first_page":"TPS293","last_page":"TPS293"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8198000192642212,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8198000192642212,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.17270000278949738,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tivozanib","display_name":"tivozanib","score":1.0},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cold-tumors","display_name":"cold tumors","score":0.968999981880188},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.6899999976158142},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.7820000052452087},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7319999933242798},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6840000152587891},{"id":"https://openalex.org/keywords/vegf-secretion","display_name":"VEGF secretion","score":0.5189999938011169},{"id":"https://openalex.org/keywords/dendritic-cell-differentiation","display_name":"dendritic cell differentiation","score":0.6499999761581421},{"id":"https://openalex.org/keywords/tumor-vasculature","display_name":"tumor vasculature","score":0.593999981880188},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.5870000123977661},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.367000013589859},{"id":"https://openalex.org/keywords/dose-de-escalation","display_name":"dose de-escalation","score":0.8379999995231628},{"id":"https://openalex.org/keywords/simon-s-two-stage-design","display_name":"Simon two-stage design","score":0.7260000109672546}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.8578323125839233},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8387222290039062},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.653343141078949},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5117683410644531},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4725120961666107},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4554363191127777},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.4518605172634125},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4340721368789673},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.42727792263031006},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28317177295684814},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2724793553352356}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.6_suppl.tps293","doi":"https://doi.org/10.1200/jco.2023.41.6_suppl.tps293","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.6_suppl.tps293","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310009","display_name":"University of Florida","ror":"https://ror.org/02y3ad647"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4309293957","https://openalex.org/W4205477962","https://openalex.org/W3031077210","https://openalex.org/W7162666352","https://openalex.org/W3192431492","https://openalex.org/W4391303224","https://openalex.org/W4317891387","https://openalex.org/W3083951977","https://openalex.org/W2889640189","https://openalex.org/W3006842830"],"abstract_inverted_index":{"TPS293":[0],"Background:":[1],"Castrate":[2],"resistant":[3],"prostate":[4],"cancer":[5],"(CRPC)":[6],"is":[7,133,175,270,312],"an":[8,43,338],"immunologically":[9,127,143,331],"cold":[10,128,144,332],"tumor,":[11],"with":[12,337],"a":[13,29,134,180,187,215,224,238,273,322],"5%":[14],"response":[15,153,182],"rate":[16,154,183],"reported":[17],"to":[18,39,105,177,186,229,235,301],"the":[19,34,40,58,70,92,108,111,115,151,168,210,286,345],"PD-L1":[20,116],"inhibitor":[21,86,117,340],"pembrolizumab.":[22],"VEGF":[23,51,66],"secreted":[24],"by":[25,76,406],"tumors":[26,333],"may":[27,47,67,119],"play":[28],"key":[30],"role":[31],"in":[32,91,122,141,344,376],"hindering":[33],"anti-tumor":[35],"immune":[36,49,78],"response,":[37],"leading":[38],"development":[41],"of":[42,60,65,72,94,110,167,190,226,257,275,289,297,307,324,398],"abnormal":[44],"vasculature":[45],"that":[46],"limit":[48],"surveillance.":[50],"also":[52],"inhibits":[53],"dendritic":[54],"cell":[55],"differentiation,":[56],"limiting":[57],"presentation":[59],"tumor":[61,421],"antigens.":[62],"The":[63,131,160,173,242,255],"inhibition":[64],"therefore":[68],"potentiate":[69],"effect":[71],"PD-1/L1":[73],"directed":[74],"therapy":[75,375],"enabling":[77],"surveillance":[79],"and":[80,84,98,114,124,150,205,261,327,393,403],"antigen":[81],"presentation.":[82],"VEGF-TKI":[83,112],"checkpoint":[85],"combinations":[87],"are":[88,148,253],"currently":[89],"approved":[90],"treatment":[93],"advanced":[95,326,346],"kidney,":[96],"cervical,":[97],"endometrial":[99],"cancers.":[100],"This":[101],"signal-seeking":[102],"study":[103,140,169,174],"aims":[104],"determine":[106],"whether":[107],"combination":[109],"tivozanib":[113,290],"atezolizumab":[118],"be":[120,203,221,233,246],"effective":[121],"CRPC":[123],"certain":[125,325,355],"other":[126],"tumors.":[129,145],"Methods:":[130],"trial":[132,428],"single":[135],"center":[136],"phase":[137,161],"Ib/II":[138],"basket":[139],"multiple":[142],"Co-primary":[146],"endpoints":[147],"safety":[149],"overall":[152],"as":[155,184],"measured":[156],"via":[157],"RECIST":[158,407],"v1.1.":[159,408],"Ib":[162],"3+3":[163],"dose":[164,274,288],"de-escalation":[165],"portion":[166],"has":[170],"been":[171],"completed.":[172],"designed":[176],"test":[178],"for":[179,223,237,294,304],"25%+":[181],"compared":[185],"null":[188,243],"hypothesis":[189,244],"<7%":[191],"(one-sided":[192],"alpha":[193],"=":[194],"0.05;":[195],"80%":[196],"power).":[197],"A":[198,281],"Simon\u2019s":[199],"two-stage":[200],"design":[201],"will":[202,220,232,245,264],"utilized":[204],"if":[206,248],"\u22652":[207],"responses":[208,252],"among":[209],"first":[211],"16":[212],"evaluable":[213,218],"patients,":[214],"further":[216],"10":[217],"patients":[219],"accrued":[222],"total":[225],"26.":[227],"Up":[228],"33":[230],"subjects":[231],"enrolled":[234],"account":[236],"20%":[239],"dropout":[240],"rate.":[241],"rejected":[247],"at":[249,272,370,399],"least":[250,371,400],"5":[251],"observed.":[254],"University":[256],"Florida's":[258],"Data":[259],"Integrity":[260],"Safety":[262],"Committee":[263],"review":[265],"significant":[266],"adverse":[267],"events.":[268],"Atezolizumab":[269],"given":[271],"1,680":[276],"mg":[277],"every":[278],"28":[279],"days.":[280],"subsequent":[282],"protocol":[283],"amendment":[284],"decreased":[285],"starting":[287],"from":[291],"1.34":[292],"mg/day":[293,303],"21":[295,305],"days":[296,306],"each":[298,308],"28-day":[299,309],"cycle":[300],"0.89":[302],"cycle.":[310],"Treatment":[311],"until":[313],"disease":[314,405],"progression":[315],"or":[316,329,341,347,352,367,383,419],"intolerance.":[317],"Key":[318,409],"inclusion":[319],"criteria":[320,411],"include":[321,412],"diagnosis":[323],"unresectable":[328],"metastatic":[330,348],"(CRPC":[334],"previously":[335],"treated":[336],"androgen":[339],"cytotoxic":[342],"chemotherapy":[343],"setting,":[349,378],"bile":[350],"duct":[351],"gallbladder":[353],"cancer,":[354,361],"HR-negative":[356],"HER2-positive":[357],"breast":[358],"cancers,":[359],"ovarian":[360],"pancreatic":[362],"adenocarcinoma,":[363],"soft":[364],"tissue":[365],"sarcoma,":[366],"vulvar":[368],"cancer),":[369],"one":[372],"prior":[373],"systemic":[374],"this":[377],"ECOG":[379,384],"0-1":[380],"(phase":[381,386],"Ib)":[382],"0-2":[385],"II),":[387],"age":[388],"\u2265":[389],"18,":[390],"adequate":[391],"hematologic":[392],"end-organ":[394],"function,":[395],"life":[396],"expectancy":[397],"12":[401],"weeks,":[402],"measurable":[404],"exclusion":[410],"known":[413],"mismatch":[414],"repair":[415],"deficiency,":[416],"microsatellite":[417],"instability,":[418],"high":[420],"mutational":[422],"burden.":[423],"Active":[424],"enrollment":[425],"continues.":[426],"Clinical":[427],"information:":[429],"NCT05000294":[430],".":[431]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2023-03-15T00:00:00"}